Sign up for updates
For sales enquiries and trials outside Auckland
For all other trials and sales enquiries please contact the team at firstname.lastname@example.org.
For all media enquires please contact the team at email@example.com with your contact details and request. Images and video of the Axon product are available upon request.
New Zealand neuroscience company Exsurgo has appointed experienced senior engineering executive, Jiva Muthu as Chief Operating Officer. Muthu joins Exsurgo from Rakon – one of the world’s la…READ
June 16, 2021
At Exsurgo, our vision is to unlock the power of neuroscience to ease suffering and enhance human potential. We’re on a mission to transform the way the world treats neurological problems with effec…READ
June 10, 2021
New Zealand neuroscience company Exsurgo announces success of breakthrough chronic pain management trial, UK study paves the way for larger clinical trial due to start soon in NZ
A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by neuroscience company, Exsurgo. Chronic pain (defined as pain that persists f…READ
June 3, 2021
Background: As many as 80% of stroke survivors experience upper limb (UL) disability. The strong relationships between disability, lost productivity, and ongoing healthcare costs mean reducing disabil…READ
June 17, 2020
Exsurgo has begun a potentially ground-breaking UK-based clinical trial to determine the effectiveness of Axon, a user-friendly neurofeedback product that treats the primary and secondary symptoms of …READ
June 15, 2020